WHO ICTRP trial
An Investigational Drug Study to Assess Weight Loss in Patients With Type 2…
PER-097-06 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-097-06 |
|---|---|
| Public title | An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011) |
| Scientific title | A Phase IIb/III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of MK-0364 in Overweight and Obese Patients With Type 2 Diabetes Mellitus (T2DM) |
| Primary sponsor | MERCK SHARP & DOHME PERU S.R.L., |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Philippines;India;Malasya;Taiwan;Lithuania;Poland;Russian Federation;Sweden;Canada;Peru;United States |
| Conditions | -E118 Non-insulin-dependent diabetes mellitus, with unspecified complications -E669 Obesity, unspecified Non-insulin-dependent diabetes mellitus, with unspecified complications Obesity, unspecified;E118;E669;Non-insulin-dependent diabetes… |
| Interventions | Group name:GROUP 1 Type of group;1 N° of participants:125 Intervention(s) description:This group will be treated with MK-0364 Placebo, in capsule, PO, QD for 2 weeks. Subsequent to this will start with MK-0364, in capsule, at a dose of 2… |
| Registration date | May 1, 2007 |
| Target size | 109 |
| Secondary IDs | NA;NCT00430742 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: